• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.Toll 样受体激动剂增强浆细胞样树突状细胞介导的不同 HIV-1 疾病进展表型中 HIV 特异性 T 细胞反应。
EBioMedicine. 2023 May;91:104549. doi: 10.1016/j.ebiom.2023.104549. Epub 2023 Apr 3.
2
Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.Toll 样受体 7(TLR-7)和 TLR-9 激动剂增强浆细胞样树突状细胞对丙型肝炎病毒复制和感染的抑制作用。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01219-18. Print 2018 Dec 1.
3
Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?DNA反应性B淋巴细胞能否通过涉及BCR/TLR-9途径的HIV-1 DNA刺激而被激活,从而产生靶向病毒DNA的抗体?
Med Hypotheses. 2014 Dec;83(6):659-63. doi: 10.1016/j.mehy.2014.09.012. Epub 2014 Sep 18.
4
Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.浆细胞样树突状细胞数量以及对Toll样受体7和9激动剂的反应在1型人类免疫缺陷病毒感染个体中因临床状态而异。
AIDS Res Hum Retroviruses. 2013 Mar;29(3):501-10. doi: 10.1089/aid.2012.0200. Epub 2013 Jan 15.
5
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.Toll样受体配体调节树突状细胞以增强巨细胞病毒和HIV-1特异性T细胞反应。
J Immunol. 2003 Oct 15;171(8):4320-8. doi: 10.4049/jimmunol.171.8.4320.
6
Impaired activation of plasmacytoid dendritic cells toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift.黑色素瘤来源的免疫抑制性细胞因子和代谢漂移介导了浆细胞样树突状细胞 toll 样受体 7/9 和 STING 的激活受损。
Front Immunol. 2024 Jan 3;14:1227648. doi: 10.3389/fimmu.2023.1227648. eCollection 2023.
7
Tim-3 is a Marker of Plasmacytoid Dendritic Cell Dysfunction during HIV Infection and Is Associated with the Recruitment of IRF7 and p85 into Lysosomes and with the Submembrane Displacement of TLR9.Tim-3是HIV感染期间浆细胞样树突状细胞功能障碍的标志物,与IRF7和p85募集到溶酶体以及TLR9的膜下移位有关。
J Immunol. 2017 Apr 15;198(8):3181-3194. doi: 10.4049/jimmunol.1601298. Epub 2017 Mar 6.
8
Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: implication for post-transplantation toll-like receptor ligand-based immunotherapy.儿童脐血移植后浆细胞样树突状细胞产生α干扰素受损:对移植后基于Toll样受体配体的免疫治疗的意义
Biol Blood Marrow Transplant. 2014 Oct;20(10):1501-7. doi: 10.1016/j.bbmt.2014.06.007. Epub 2014 Aug 14.
9
A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.一种C类含CpG的Toll样受体9激动剂成功地诱导了来自慢性丙型肝炎感染患者的浆细胞样树突状细胞产生大量干扰素-α。
J Viral Hepat. 2009 May;16(5):315-24. doi: 10.1111/j.1365-2893.2008.01011.x. Epub 2009 Feb 24.
10
Phthalates suppress type I interferon in human plasmacytoid dendritic cells via epigenetic regulation.邻苯二甲酸酯通过表观遗传调控抑制人浆细胞样树突状细胞的 I 型干扰素。
Allergy. 2013 Jul;68(7):870-9. doi: 10.1111/all.12162. Epub 2013 Jun 5.

引用本文的文献

1
Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development.基孔肯雅病毒感染中的Toll样受体(TLR)反应:激活机制、免疫逃逸以及TLR激动剂在疫苗开发中的应用
Vaccines (Basel). 2025 Aug 13;13(8):856. doi: 10.3390/vaccines13080856.
2
Antisense oligonucleotides targeting IRF4 alleviate psoriasis.靶向IRF4的反义寡核苷酸可缓解银屑病。
Acta Pharm Sin B. 2025 Jul;15(7):3575-3590. doi: 10.1016/j.apsb.2025.05.004. Epub 2025 May 14.
3
Toll-like receptor response to Zika virus infection: progress toward infection control.Toll样受体对寨卡病毒感染的反应:感染控制方面的进展
Npj Viruses. 2025 Mar 13;3(1):20. doi: 10.1038/s44298-025-00102-3.
4
Innate Immune Cell Functions Contribute to Spontaneous HIV Control.先天免疫细胞功能有助于 HIV 的自发控制。
Curr HIV/AIDS Rep. 2024 Nov 30;22(1):6. doi: 10.1007/s11904-024-00713-0.
5
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance.HIV-1 来源的单链 RNA-寡核苷酸的感应诱导精氨酸酶 1 介导的耐受。
Cells. 2024 Jun 23;13(13):1088. doi: 10.3390/cells13131088.
6
TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.Toll样受体激动剂作为预防病毒感染的疫苗佐剂:概述
Front Microbiol. 2023 Dec 21;14:1249718. doi: 10.3389/fmicb.2023.1249718. eCollection 2023.
7
MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors.miR-155 负调控 HIV 感染者中的抗病毒先天免疫反应。
Viruses. 2023 Nov 1;15(11):2206. doi: 10.3390/v15112206.
8
Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview.Toll 样受体对人类免疫缺陷病毒 1 或乙型肝炎或丙型肝炎病毒合并感染的反应:概述。
Int J Mol Sci. 2023 Jun 1;24(11):9624. doi: 10.3390/ijms24119624.

Toll 样受体激动剂增强浆细胞样树突状细胞介导的不同 HIV-1 疾病进展表型中 HIV 特异性 T 细胞反应。

Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes.

机构信息

Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Seville, Spain.

Immunology Section, Laboratorio InmunoBiología Molecular (LIBM), Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Area of Immune System Pathology, Madrid, Spain.

出版信息

EBioMedicine. 2023 May;91:104549. doi: 10.1016/j.ebiom.2023.104549. Epub 2023 Apr 3.

DOI:10.1016/j.ebiom.2023.104549
PMID:37018973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10106920/
Abstract

BACKGROUND

Plasmacytoid dendritic cells (pDCs) sense viral and bacterial products through Toll-like receptor (TLR)-7 and -9 and translate this sensing into Interferon-α (IFN-α) production and T-cell activation. The understanding of the mechanisms involved in pDCs stimulation may contribute to HIV-cure immunotherapeutic strategies. The objective of the present study was to characterize the immunomodulatory effects of TLR agonist stimulations in several HIV-1 disease progression phenotypes and in non HIV-1 infected donors.

METHODS

pDCs, CD4 and CD8 T-cells were isolated from 450 ml of whole blood from non HIV-1 infected donors, immune responders (IR), immune non responders (INR), viremic (VIR) and elite controller (EC) participants. pDCs were stimulated overnight with AT-2, CpG-A, CpG-C and GS-9620 or no stimuli. After that, pDCs were co-cultured with autologous CD4 or CD8 T-cells and with/without HIV-1 (Gag peptide pool) or SEB (Staphylococcal Enterotoxin B). Cytokine array, gene expression and deep immunophenotyping were assayed.

FINDINGS

pDCs showed an increase of activation markers levels, interferon related genes, HIV-1 restriction factors and cytokines levels after TLR stimulation in the different HIV-disease progression phenotypes. This pDC activation was prominent with CpG-C and GS-9620 and induced an increase of HIV-specific T-cell response even in VIR and INR comparable with EC. This HIV-1 specific T-cell response was associated with the upregulation of HIV-1 restriction factors and IFN-α production by pDC.

INTERPRETATION

These results shed light on the mechanisms associated with TLR-specific pDCs stimulation associated with the induction of a T-cell mediated antiviral response which is essential for HIV-1 eradication strategies.

FUNDING

This work was supported by Gilead fellowship program, the Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional, FEDER, "a way to make Europe") and the Red Temática de Investigación Cooperativa en SIDA and by the Spanish National Research Council (CSIC).

摘要

背景

浆细胞样树突状细胞(pDCs)通过 Toll 样受体(TLR)-7 和 -9 感知病毒和细菌产物,并将这种感应转化为干扰素-α(IFN-α)的产生和 T 细胞的激活。了解 pDCs 刺激的机制可能有助于 HIV 治愈的免疫治疗策略。本研究的目的是描述 TLR 激动剂刺激在几种 HIV-1 疾病进展表型和非 HIV-1 感染供体中的免疫调节作用。

方法

从非 HIV-1 感染供体、免疫应答者(IR)、免疫无应答者(INR)、病毒血症(VIR)和精英控制者(EC)参与者的 450ml 全血中分离出 pDCs、CD4 和 CD8 T 细胞。pDCs 用 AT-2、CpG-A、CpG-C 和 GS-9620 或无刺激物过夜刺激。之后,将 pDCs 与自体 CD4 或 CD8 T 细胞共培养,并与/或不与 HIV-1(Gag 肽库)或 SEB(葡萄球菌肠毒素 B)共培养。测定细胞因子阵列、基因表达和深度免疫表型。

结果

在不同的 HIV 疾病进展表型中,TLR 刺激后,pDCs 显示出激活标志物水平、干扰素相关基因、HIV-1 限制因子和细胞因子水平的增加。这种 pDC 激活在 CpG-C 和 GS-9620 中更为明显,并诱导即使在 VIR 和 INR 中也可与 EC 相媲美的 HIV 特异性 T 细胞反应。这种 HIV-1 特异性 T 细胞反应与 pDC 中 HIV-1 限制因子和 IFN-α的上调有关。

结论

这些结果揭示了与 TLR 特异性 pDCs 刺激相关的机制,该机制与诱导 T 细胞介导的抗病毒反应有关,这对于 HIV-1 清除策略至关重要。

资助

这项工作得到了吉利德奖学金计划、西班牙卡洛斯三世健康研究所(欧洲区域发展基金,FEDER)和合作性艾滋病研究主题网络以及西班牙国家研究理事会(CSIC)的支持。